中国心连心化肥(01866.HK)前三季度收入70.35亿元 同比维持稳定
格隆汇11月22日丨中国心连心化肥(01866.HK)公布,2019年前三季度,集团实现未经审计综合收入为70.35亿元,对比2018年前三季度的综合收入70.83亿元,维持稳定。另外集团2019年第三季度实现未经审计收入22.39亿元。集团2019年前三季度的未经审计综合纯利约人民币4.12亿。2019年第三季度,集团的未经审计综合纯利约人民币0.95亿。
虽然宏观经济环境复杂多变,集团将继续坚持低成本和差异化的竞争策略,使高效肥的销售比重持续提高,进一步提升化肥产品的盈利能力和市场竞争力。同时利用自身煤气化工生产优势,丰富煤化工产品种类,并根据化肥和化工产品的盈利能力灵活调整产品结构,进一步提升集团盈利能力和抗风险能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.